Sofia N. Chatziioannou
St Lukes Episcopal Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sofia N. Chatziioannou.
Circulation | 1999
Sofia N. Chatziioannou; Warren H. Moore; Patrick V. Ford; Ronald E. Fisher; Vei-Vei Lee; Carina Alfaro-Franco; Ramesh D. Dhekne
BACKGROUNDnAlthough high exercise tolerance is associated with an excellent prognosis, the significance of abnormal myocardial perfusion imaging (MPI) in patients with high exercise tolerance has not been established. This study retrospectively compares the utility of MPI and exercise ECG (EECG) in these patients.nnnMETHODS AND RESULTSnOf 388 consecutive patients who underwent exercise MPI and reached at least Bruce stage IV, 157 (40.5%) had abnormal results and 231 (59.5%) had normal results. Follow-up was performed at 18+/-2.7 months. Adverse events, including revascularization, myocardial infarction, and cardiac death, occurred in 40 patients. Nineteen patients had revascularization related to the MPI results or the patients condition at the time of MPI and were not included in further analysis. Seventeen patients (12.2%) with abnormal MPI and 4 (1.7%) with normal MPI had adverse cardiac events (P<0.001). Cox proportional-hazards regression analysis showed that MPI was an excellent predictor of cardiac events (global chi2=13.2; P<0.001; relative risk=8; 95% CI=3 to 23) but EECG had no predictive power (global chi2=0.05; P=0.8; relative risk=1; 95% CI=0.4 to 3.0). The addition of Dukes treadmill score risk categories did not improve the predictive power of EECG (global chi2=0.17). The predictive power of the combination of EECG (including Duke score categories) and MPI was no better than that of MPI alone (global chi2=13.5).nnnCONCLUSIONSnUnlike EECG, MPI is an excellent prognostic indicator for adverse cardiac events in patients with known or suspected CAD and high exercise tolerance.
The Journal of Nuclear Medicine | 2001
Patrick V. Ford; Sofia N. Chatziioannou; Warren H. Moore; Ramesh D. Dhekne
Surgery | 2000
Sofia N. Chatziioannou; Warren H. Moore; Patrick V. Ford; Ramesh D. Dhekne
Texas Heart Institute Journal | 1999
Sofia N. Chatziioannou; C Alfaro-Franco; Warren H. Moore; L Alanis-Williams; Ramesh D. Dhekne; Patrick V. Ford
Clinical Cardiology | 2001
Sofia N. Chatziioannou; Warren H. Moore; Ramesh D. Dhekne; Patrick V. Ford
Texas Heart Institute Journal | 2000
Sofia N. Chatziioannou; Warren H. Moore; Ramesh D. Dhekne; Patrick V. Ford
Clinical Nuclear Medicine | 1998
Sofia N. Chatziioannou; Warren H. Moore; Patrick V. Ford; Ramesh D. Dhekne
Clinical Nuclear Medicine | 1999
Sofia N. Chatziioannou; Warren H. Moore; K. Kadipasaoglu; O. H. Frazier; Patrick V. Ford; Ramesh D. Dhekne; D. A. Cooley
Clinical Nuclear Medicine | 1998
Sofia N. Chatziioannou; Warren H. Moore; Patrick V. Ford; Ramesh D. Dhekne
Clinical Nuclear Medicine | 1998
Sofia N. Chatziioannou; Warren H. Moore; Ramesh D. Dhekne; Patrick V. Ford